Combination of EUTOS Score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy

Tiribelli Mario; Binotto Gianni; Calistri Elisabetta; Maino Elena; Scaffidi Luigi; Medeot Marta; Nabergoj Mitja; Ambrosetti Achille; Semenzato Gianpietro; Fanin Renato; Bonifacio Massimiliano

首页> 外文期刊>American Journal of Hematology >Combination of EUTOS Score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy

【24h】

Combination of EUTOS Score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy

机译：结合EUTOS评分和3个月的BCR-ABL转录水平，可以确定一组对一线伊马替尼治疗反应良好的高危慢性粒细胞白血病患者

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《American Journal of Hematology》 |2015年第7期|共3页
作者
Tiribelli Mario; Binotto Gianni; Calistri Elisabetta; Maino Elena; Scaffidi Luigi; Medeot Marta; Nabergoj Mitja; Ambrosetti Achille; Semenzato Gianpietro; Fanin Renato; Bonifacio Massimiliano;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Combination of EUTOS Score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy [J] . Tiribelli Mario, Binotto Gianni, Calistri Elisabetta, American Journal of Hematology . 2015,第7期

机译：结合EUTOS评分和3个月的BCR-ABL转录水平，可以确定一组对一线伊马替尼治疗反应良好的高危慢性粒细胞白血病患者
2. Classification of Patients With Chronic Myeloid Leukemia on Basis of BCR-ABL Transcript Level at 3 Months Fails to Identify Patients With Low Organic Cation Transporter-1 Activity Destined to Have Poor Imatinib Response. [J] . Deborah L White, Timothy P Hughes Journal of Clinical Oncology . 2012,第10期

机译：根据3个月的BCR-ABL转录水平对慢性粒细胞白血病患者进行分类，未能识别出注定对伊马替尼反应不良的有机阳离子转运蛋白1活性低的患者。
3. Predictive value of pretreatment BCR-ABL~(IS) transcript level on response to imatinib therapy in Egyptian patients with chronic phase chronic myeloid leukemia (CPCML) [J] . El-Metnawy W.H., Mattar M.M., El-Nahass Y.H., International Journal of Biomedical Science . 2013,第1期

机译：埃及慢性慢性粒细胞白血病（CPCML）患者的治疗前BCR-ABL〜（IS）转录水平对依马替尼治疗反应的预测价值
4. Combination effects of repetitive pulsed magnetic stimulation and tyrosine kinase inhibitor imatinib for chronic myeloid leukemia cell line TCC-S [C] . S. Yamaguchi, M. Sekino, Y. Sato, Intermag Conference . 2006

机译：重复脉冲磁刺激和酪氨酸激酶抑制剂慢性髓性白血病细胞系TCC-S的组合效应
5. Influences on physician recommendation for imatinib mesylate in chronic phase chronic myeloid leukemia patients. [D] . Iyer, Shrividya Sethuraman. 2003

机译：对慢性期慢性粒细胞白血病患者甲磺酸伊马替尼的医师推荐的影响。
6. Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy [O] . Masayuki Shiseki, Chikashi Yoshida, Naoki Takezako, -1

机译：达沙替尼可快速诱导慢性阶段性髓样白血病患者的深层分子反应这些患者通过伊马替尼治疗可达到可检测水平的BCR-ABL1转录本从而达到主要分子反应
7. Combination of eutos score and 3-month bcr-abl transcript level identifies a group of good-risk chronic myeloid leukemia patients with favourable response to frontline imatinib therapy. [O] . Tiribelli M, Binotto G, Calistri E, Maino E, Scaffidi L, Medeot M, Nabergoj M, Ambrosetti A, Semenzato G, Fanin R, Bonifacio M, Gruppo Triveneto LMC. 2015

机译：结合eutos评分和3个月的bcr-abl转录水平，可以确定一组对一线伊马替尼治疗有良好反应的高危慢性髓性白血病患者。

Combination of EUTOS Score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy

著录项

引文网络

相似文献

相关主题

期刊订阅